U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Singhal Anil K. (0001982984)
Mailing Address
C/O TRISALUS LIFE SCIENCES, INC.
6272 W. 91ST AVENUE
WESTMINSTER CO 80031
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Werewolf Therapeutics, Inc. 0001785530 2025-02-19 director
MedTech Acquisition Corp
Current Name:TriSalus Life Sciences, Inc.
0001826667 2023-08-10 director


Items 1 - 8

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2025-02-19   Werewolf Therapeutics, Inc. 4 A-Award --D 45000.0000 45000.0000 1 0001785530 Stock Option (right to buy)
A 2024-08-13   TriSalus Life Sciences, Inc. 4 A-Award --D 15000.0000 15000.0000 1 0001826667 Director stock option (right to buy)
A 2023-08-10   TriSalus Life Sciences, Inc. 4 A-Award --D 35000.0000 35000.0000 1 0001826667 Stock Option (right to buy)
- -   TriSalus Life Sciences, Inc. 3 - --D 1 0001826667 Stock Option (right to buy)
- -   TriSalus Life Sciences, Inc. 3 - --D 2 0001826667 Stock Option (right to buy)
- -   TriSalus Life Sciences, Inc. 3 - --D 3 0001826667 Stock Option (right to buy)
- -   TriSalus Life Sciences, Inc. 3 - --D 4 0001826667 Stock Option (right to buy)
- -   Werewolf Therapeutics, Inc. 3 - --- 1 - -

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016